ABVC

Conviction 63HealthcareScan · Thu, Jun 25, 2026

ABVC$1.44+8.27%

ResistanceSupportVol 14

Vol MA14 402.09K

Mar 26Apr 14May 1May 19Jun 8Jun 25

ABVC BIOPHARMA, INC.PHARMACEUTICAL PREPARATIONSwww.abvcpharma.com ↗

Price1.44

Change+8.27%

Gap+0.75%

Rel volume32.19×

Avg volume322.12K

Avg $ vol450.71K

SMA 201.33

SMA 501.21

SMA 2001.96

Price vs 50+19.01%

Price vs 200-26.45%

MA stackmixed

50/200 cross—

Supertrendup · 1.10

RSI (14)62

MACD hist0.00

MACD crossbull · 0d

Stoch %K / %D68 / 52

ADX (14)22

+DI / −DI26 / 10

RSI divergence—

MACD divergence—

ATR %+8.59%

ADR %9.26%

52w high4.74

52w low0.9094

From 52w high-69.62%

Above 52w low+58.35%

New 52w highNo

SqueezeOn · 4d

Bollinger width18.66%

%B0.95

Donchian pos67.57%

Donchian high1.56

Donchian low1.19

AVWAP (52w high)2.52

vs AVWAP high-42.93%

AVWAP (52w low)1.33

vs AVWAP low+8.04%

OBV trendUp

Chaikin MF (20)-0.10

Today vs 20d32.19×

Avg vol (14d)402.09K

Avg vol (20d)322.12K

Avg $ vol (20d)450.71K

Market cap37.44M

RS 3m (vs SPY)+5.44%

RS 6m (vs SPY)-47.01%

RS line new highNo

Trend template3/8

Technical rank41.2

1 week+5.88%

1 month+11.63%

3 months+33.33%

6 months-38.72%

1 year-30.10%

YTD-34.25%

P/E-4.73

P/B3.48

P/S73.47

P/FCF-12.45

EPS-0.3900

Div yield—

ROE-73.41%

ROA-40.08%

Debt/Eq0.02

Current0.12

EV/EBITDA-5.26

Gross margin99.85%

Net margin—

Rev growth0.00%

EPS growth-61.30%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value37.51M

Revenue795.95K

Net income-1.56M

Gross profit795.95K

Free cash flow-3.01M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out26M

Employees19

ListedTue, Nov 9, 2004

Free float20.61M

Float %81.0%

Short interest258.9K

Days to cover1.8d

Short volume27.1%

Squeeze score26 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction63 / 100

Pattern quality—

Tech rank41.2 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.47

Support1.00

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ABVC

All disclosures →

No recent disclosed trades by Congress in ABVC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ABVC

No recent insider (Form 4) filings in ABVC. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ABVC

EDGAR →

No recent SEC filings on file for ABVC.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.